Charles B. Pratt

Q: What Schools Are Affiliated With Charles B. Pratt

Charles B. Pratt is affiliated with the following schools: University of Arkansas for Medical Sciences, University of Tennessee Health Science Center

Charles B. Pratt's AcademicInfluence.com Rankings

Charles B. Pratt

Philosophy

#7094

World Rank

#10255

Historical Rank

Logic

#4171

World Rank

#5431

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Charles B. Pratt Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Charles B. Pratt's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. (1986) (1065)
Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. (1977) (638)
Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas. (1996) (332)
St. Jude Children's Research Hospital. (1997) (321)
Central nervous system therapy and combination chemotherapy of childhood lymphocytic leukemia. (1971) (318)
High‐dose methotrexate‐induced nephrotoxicity in patients with osteosarcoma (2004) (260)
Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital. (1998) (258)
Direct translation of a protracted irinotecan schedule from a xenograft model to a phase I trial in children. (1999) (226)
Drug dosage and remission duration in childhood lymphocytic leukemia (1971) (219)
DECHLOROETHYLATION OF IFOSFAMIDE AND NEUROTOXICITY (1986) (206)
Metastases detected at the time of diagnosis of primary pediatric extremity osteosarcoma at diagnosis (1999) (190)
Survival after recurrence of Ewing Tumors (2002) (153)
Treatment of intraocular retinoblastoma with vincristine and carboplatin. (2003) (152)
Colorectal carcinoma in childhood and adolescence: a clinicopathologic review. (2007) (152)
Saturable pharmacokinetics and paclitaxel pharmacodynamics in children with solid tumors. (1994) (144)
Coordinated treatment of childhood rhabdomyosarcoma with surgery, radiotherapy, and combination chemotherapy. (1972) (142)
Malignant germ cell tumors in 57 children and adolescents (1981) (140)
Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. (1995) (139)
Topotecan in Pediatric Patients With Recurrent and Progressive Solid Tumors: A Pediatric Oncology Group Phase II Study (1998) (139)
Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children's Research Hospital. (1999) (135)
Phase I Trial and Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Topotecan Using a Five‐Day Course in Children with Refractory Solid Tumors: A Pediatric Oncology Group Study (1996) (132)
Phase I study of topotecan for pediatric patients with malignant solid tumors. (1994) (132)
Ifosfamide, Fanconi's syndrome, and rickets. (1991) (129)
Colon carcinoma in children and adolescents. A review of 30 cases (1985) (121)
A phase I study of irinotecan in pediatric patients: a pediatric oncology group study. (2001) (121)
Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: a feasibility study at St. Jude Children's Research Hospital. (1999) (118)
Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/mesna. (1986) (116)
Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephrotoxicity by prior cis-diamminedichloroplatinum(II) therapy. (1987) (114)
Improved prognosis of children with osteosarcoma metastatic to the lung(s) at the time of diagnosis (1992) (114)
Bone sarcomas of the head and neck in children (2000) (112)
An evaluation of the impact of a self-care coping intervention on psychological and clinical outcomes in adolescents with newly diagnosed cancer. (2000) (112)
Myeloid neoplasia in children treated for solid tumours (1990) (111)
Clinical features and outcome of initially unresected nonmetastatic pediatric nonrhabdomyosarcoma soft tissue sarcoma. (2002) (109)
Thoracotomy for pulmonary metastatic osteosarcoma. An analysis of prognostic indicators of survival (1987) (108)
Treatment of clinically localized Ewing's sarcoma with radiotherapy and combination chemotherapy (1972) (104)
Role of adjuvant chemotherapy in the treatment of surgically resected pediatric nonrhabdomyosarcomatous soft tissue sarcomas: A Pediatric Oncology Group Study. (1999) (102)
Ifosfamide/etoposide combination in the treatment of recurrent malignant solid tumors of childhood. A pediatric oncology group phase II study (1993) (102)
Clinical pharmacodynamics of continuous infusion topotecan in children: systemic exposure predicts hematologic toxicity. (1994) (98)
Synovial sarcoma in children and adolescents: the St Jude Children's Research Hospital experience. (1994) (97)
Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone. (1992) (94)
Carboplatin/ifosfamide window therapy for osteosarcoma: results of the St Jude Children's Research Hospital OS-91 trial. (2001) (93)
Childhood carcinoid tumors: the St Jude Children's Research Hospital experience. (2000) (92)
Outcome of treatment for childhood cancer in black as compared with white children. The St Jude Children's Research Hospital experience, 1962 through 1992. (1995) (91)
Alveolar soft part sarcoma in children and adolescents: clinical features and outcome of 11 patients. (1996) (90)
Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study. (2005) (90)
An exploratory study of environmental and medical factors potentially related to childhood cancer. (1991) (90)
Multiagent chemotherapy as neoadjuvant treatment for multifocal intraocular retinoblastoma. (2001) (88)
Phase I trial of paclitaxel in children with refractory solid tumors: a Pediatric Oncology Group Study. (1993) (87)
Malignant melanoma in children and adolescents (1981) (86)
Conduct of phase I trials in children with cancer. (1998) (86)
Stage‐related combined modality treatment of retinoblastoma. Results of a prospective study (1980) (85)
Treatment of metastatic retinoblastoma. (2003) (84)
Hepatic undifferentiated (embryonal) sarcoma and rhabdomyosarcoma in children. Results of therapy (1987) (84)
Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapy. (1991) (81)
Colorectal carcinoma in adolescents implications regarding etiology (1977) (81)
Treatment of unresectable or metastatic pediatric soft tissue sarcomas with surgery, irradiation, and chemotherapy: a Pediatric Oncology Group study. (1998) (81)
Age-related adriamycin cardiotoxicity in children. (1978) (79)
Second malignant neoplasms occuring in survivors of osteosarcoma (1997) (78)
Effect of pleural effusion on high‐dose methotrexate kinetics (1978) (78)
Dynamic magnetic resonance imaging of regional contrast access as an additional prognostic factor in pediatric osteosarcoma (2001) (78)
Orbital development in long-term survivors of retinoblastoma. (1997) (76)
The natural history of colorectal carcinoma in adolescents (1982) (74)
Escalating systemic exposure of continuous infusion topotecan in children with recurrent acute leukemia. (1996) (73)
Malignant melanoma in children: its management and prognosis. (1990) (73)
Phase II trial of ifosfamide in children with malignant solid tumors. (1987) (71)
Childhood multifocal osteosarcoma. Clinicopathologic and radiologic correlates (1985) (71)
The use of chemotherapy for extraocular retinoblastoma. (1985) (70)
Thyroid dysfunction and neoplasia in children receiving neck irradiation for cancer (1985) (70)
Therapy of localized and regional lymphosarcoma of childhood (1971) (69)
Brain metastases in pediatric Ewing sarcoma and rhabdomyosarcoma: the St. Jude Children's Research Hospital experience. (1999) (69)
Interpatient variability in bioavailability of the intravenous formulation of topotecan given orally to children with recurrent solid tumors (1999) (69)
Combined VM‐26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukemia (1980) (68)
Breast metastases in children with rhabdomyosarcoma (1980) (68)
Hemangiopericytoma in children and infants (2000) (67)
Metastatic nonrhabdomyosarcomatous soft-tissue sarcomas in children and adolescents: the St. Jude Children's Research Hospital experience. (1999) (67)
Effective cisplatin (DDP) based chemotherapy in the treatment of hepatoblastoma. (1985) (66)
Intrathecal arabinosyl cytosine in meningeal leukemia (1970) (62)
Ifosfamide-induced subclinical tubular nephrotoxicity despite mesna. (1987) (61)
Ifosfamide/Carboplatin/Etoposide (ICE) for Recurrent Malignant Solid Tumors of Childhood: A Pediatric Oncology Group Phase I/II Study (1995) (61)
Pharmacokinetic monitoring of high-dose methotrexate (2004) (61)
The impact of margin of resection on outcome in pediatric nonrhabdomyosarcoma soft tissue sarcoma. (1999) (60)
Neurofibromatosis type I and malignancy: review of 32 pediatric cases treated at a single institution. (1994) (60)
Adjuvant multiple drug chemotherapy for osteosarcoma of the extremity (1977) (59)
Response of childhood rhabdomyosarcoma to combination chemotherapy. (1969) (57)
Brain metastases in osteosarcoma. Report of a long‐term survivor and review of the St. Jude Children's Research Hospital experience (1993) (56)
Phase I Therapy Trials in Children With Cancer (1998) (56)
Malignant parotid tumors in patients previously treated for childhood cancer: clinical and imaging findings in eight cases. (1994) (55)
Outcome in 43 children presenting with metastatic Ewing sarcoma: the St. Jude Children's Research Hospital experience, 1962 to 1992. (1996) (55)
Tumor size as a predictor of outcome in pediatric non‐metastatic osteosarcoma of the extremity (2004) (53)
Combined therapy to prevent complete pelvic exenteration for rhabdomyosarcoma of the vagina or uterus (1976) (53)
Doxorubicin in treatment of malignant solid tumors in children. (1974) (53)
Duration and severity of fatty metamorphosis of the liver following L‐asparaginase therapy (1971) (52)
Ifosfamide neurotoxicity is related to previous cisplatin treatment for pediatric solid tumors. (1990) (52)
Hopefulness and its Characteristics in Adolescents with Cancer (1999) (51)
Comparison of daily versus weekly L-asparaginase for the treatment of childhood acute leukemia. (1970) (51)
Phase I clinical trial of recombinant human tumor necrosis factor in children with refractory solid tumors: a Pediatric Oncology Group study. (1993) (51)
Challenges in the treatment of childhood fibromatosis. (1987) (50)
Adjuvant chemotherapy for osteosarcoma of the extremity long‐term results of two consecutive prospective protocol studies (1990) (50)
Clinical trials and pharmacokinetics of intermittent high-dose methotrexate-"leucovorin rescue" for children with malignant tumors. (1974) (49)
Factors leading to delay in the diagnosis and affecting survival of children with head and neck rhabdomyosarcoma. (1978) (48)
Primary extracranial rhabdoid tumors clinicopathologic features and response to ifosfamide (1993) (48)
Hyperpigmentation of Nails From Doxorubicin (1974) (47)
Prognostic factors and imaging patterns of recurrent pulmonary nodules after thoracotomy in children with osteosarcoma (2001) (47)
Coming to terms : Parents' response to a first cancer recurrence in their child (1996) (45)
Phase I study of combination topotecan and carboplatin in pediatric solid tumors. (2002) (45)
Recovery from toxicity associated with high-dose methotrexate: prognostic factors. (1977) (45)
Bone tumors other than osteosarcoma after retinoblastoma (1993) (45)
Hamartoma (leiomyomatous type) of the kidney (1966) (44)
Therapy for childhood soft-tissue sarcomas other than rhabdomyosarcoma: a review of 62 cases treated at a single institution. (1986) (43)
Protracted intermittent schedule of topotecan in children with refractory acute leukemia: a pediatric oncology group study. (2002) (43)
Persistent hyperplastic primary vitreous of the eye: imaging findings with pathologic correlation. (1994) (43)
Metastatic epidural tumors in children. (1982) (42)
Secondary ovarian neoplasms in children: imaging features with histopathologic correlation (2001) (42)
Comparative renal tubular toxicity of chemotherapy regimens including ifosfamide in patients with newly diagnosed sarcomas. (2000) (42)
Phase I trials in pediatric oncology: perceptions of pediatricians from the United Kingdom Children's Cancer Study Group and the Pediatric Oncology Group. (2000) (42)
Primary extracranial rhabdoid tumors. Clinicopathologic features and response to ifosfamide. (1993) (42)
Recurrent childhood lymphocytic leukemia following cessation of therapy. Treatment and response (1976) (42)
Pharmacokinetic evaluation of cisplatin in children with malignant solid tumors: a phase II study. (1981) (40)
Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in treatment of newly diagnosed pediatric solid tumors. (1994) (40)
High-dose methotrexate used alone and in combination for measurable primary or metastatic osteosarcoma. (1980) (39)
The effect of prior cisplatin therapy on the pharmacokinetics of high-dose methotrexate. (1984) (39)
A new familial cancer syndrome? A spectrum of malignant and benign tumors including retinoblastoma, carcinoma of the bladder and other genitourinary tumors, thyroid adenoma, and a probable case of multifocal osteosarcoma. (1977) (39)
Malignancy in the neonate. (1989) (39)
Breast masses in women treated for childhood cancer (1998) (38)
Serum pesticide levels in patients with chiLDHOOD COLORECTAL CARCINOMA (1981) (38)
Concept of maximum tolerated systemic exposure and its application to phase I-II studies of anticancer drugs. (1991) (37)
Survival of children with neuroblastoma treated with combination chemotherapy. (1968) (36)
Clinical pharmacology of bleomycin and cisplatin. (1981) (36)
Treatment of Refractory Osteosarcoma With Fractionated Cyclophosphamide and Etoposide (2002) (35)
Phase I targeted systemic exposure study of paclitaxel in children with refractory acute leukemias. (1999) (35)
Combined therapy for malignant tumors of the chest wall in children. (1977) (35)
Dermatofibrosarcoma protuberans: the pediatric experience at St. Jude Children's Research Hospital. (1997) (34)
Topoisomerase I interactive drugs in children with cancer (2004) (34)
Patient Satisfaction After Limb-Sparing Surgery and Amputation for Pediatric Malignant Bone Tumors (1998) (34)
The use of bone marrow aspirations and lumbar punctures at the time of diagnosis of retinoblastoma. (1989) (34)
Concurrent chemotherapy and radiation therapy in the treatment of childhood and adolescent Hodgkin's disease (1974) (33)
Management of malignant solid tumors in children. (1972) (33)
Phase I study of oral etoposide in children with refractory solid tumors. (1994) (33)
Chemotherapy for extraocular retinoblastoma. (1994) (33)
Phase I study of ICRF-187 in pediatric cancer patients and comparison of its pharmacokinetics in children and adults. (1986) (33)
Role of irradiation in management of synovial sarcoma: St. Jude Children's Research Hospital experience. (1996) (33)
Pediatric extraadrenal paraganglioma. (2003) (32)
Preoperative therapy for unresectable malignant tumors in children. (1975) (32)
Ifosfamide studies for primary or recurrent pediatric malignant solid tumors and leukemia. (1990) (32)
Treatment outcome and dose-response relationship in infants younger than 1 year treated for retinoblastoma with primary irradiation. (1996) (31)
The conduct of phase I-II clinical trials in children with cancer. (1991) (31)
Fractures in children treated with radiotherapy for soft tissue sarcoma. (1996) (31)
Pediatric brachytherapy. The St. Jude children's research hospital experience (1994) (30)
Ultrastructure of malignant histiocytoma arising in the acromion. (1978) (30)
Phase I clinical and pharmacokinetic study of 4'-(9-acridinylamino)-methanesulfon-m-anisidide in children with cancer. (1980) (30)
Paratesticular rhabdomyosarcoma: Delayed effects of multimodality therapy and implications for current management (1994) (30)
Epithelioid sarcoma in children. (1996) (29)
Pediatric Phase II Cancer Chemotherapy Trials: A Pediatric Oncology Group Study (1997) (29)
Successful remission induction in children with acute lymphocytic leukemia at high risk for treatment failure (1971) (29)
Phase I clinical trial of oxaliplatin in children and adolescents with refractory solid tumors. (2007) (29)
Carcinoembryonic antigen and carbohydrate 19‐9 antigen as markers for colorectal carcinoma in children and adolescents (1992) (29)
The significance of calcified regional lymph nodes at the time of diagnosis of osteosarcoma. (1985) (29)
Second malignant neoplasms in children with retinoblastoma: the St. Jude Children's Research Hospital experience. (1995) (28)
Comparison of primary osteosarcoma of flat bones with secondary osteosarcoma of any site (1997) (28)
Limb salvage procedures for children with osteosarcoma: an alternative to amputation. (1983) (27)
The Role of Surgical Resection When Combined with Chemotherapy and Radiation in the Management of Pelvic Rhabdomyosarcoma (1984) (27)
Treatment of unresectable or metastatic osteosarcoma with cisplatin or cisplatin–doxorubicin (1985) (27)
Thiabendazole in visceral larva migrans. (1971) (27)
Mortality in pediatric phase I clinical trials. (1989) (27)
Ocular Preservation After 36 Gy External Beam Radiation Therapy for Retinoblastoma (2002) (27)
Tetany: a complication of cis-dichlorodiammineplatinum(II) therapy. (1979) (27)
Delayed gastrointestinal complications after combined modality therapy of childhood rhabdomyosarcoma. (1979) (27)
Low-dosage asparaginase treatment of childhood acute lymphocytic leukemia. (1971) (26)
Continuous infusion of interleukin‐2 in children with refractory malignancies (1993) (26)
Second cessation of therapy in childhood lymphocytic leukemia. (1979) (26)
Soft tissue sarcomas in children. (1993) (25)
A phase I study of ifosfamide given on alternate days to treat children with brain tumors (1993) (25)
Pediatric nonrhabdomyosarcomas of the extremities. Influence of size, invasiveness, and grade on outcome. (1991) (25)
Retinoblastoma: sonographic findings with pathologic correlation in pediatric patients. (2000) (25)
Use of irradiation for therapy of retinoblastoma in children more than 1 year old: the St. Jude Children's Research Hospital experience and review of literature. (1995) (25)
Some aspects of childhood cancer epidemiology. (1985) (24)
Bleomycin, cyclophosphamide, and dactinomycin in metastatic osteosarcoma: lack of tumor regression in previously treated patients. (1987) (24)
Carcinomas in children. Clinical and demographic characteristics (1988) (24)
Tubular nephrotoxicity during long-term ifosfamide and mesna therapy (2004) (23)
Complications of pelvic exenteration in children who have genitourinary rhabdomyosarcoma. (1997) (23)
Osteosarcoma in 2 Very Young Children (1977) (22)
Management and prognosis of head and neck sarcomas. (1989) (22)
Amoxycillin levels in sputum, serum, and saliva (1974) (21)
Combination chemotherapy for osteosarcoma. (1978) (21)
Successful treatment of a radiation-associated extradural osteosarcoma with chemotherapy in an adolescent girl. (1989) (20)
Brain metastases in children with melanoma (1997) (20)
IMMUNOTHERAPY OF OSTEOSARCOMA PATIENTS WITH VIRUS‐MODIFIED TUMOR CELLS * (1976) (20)
Cancer chemotherapy-induced tubular nephrotoxicity evaluated by immunochemical determination of urinary adenosine deaminase binding protein. (1986) (20)
Soft tissue sarcoma of the hand in children: clinical outcome and management. (1997) (20)
Thallium bone imaging as an indicator of response and outcome in nonmetastatic primary extremity osteosarcoma (2001) (19)
Treatment strategy for nodular renal blastema and nephroblastomatosis associated with Wilms' tumor. (1978) (19)
Capsular and vascular invasion: important prognostic factors in Wilms' tumor. (1975) (19)
Epipodophyllotoxins in the treatment of childhood cancer (2004) (19)
Mesna excretion and ifosfamide nephrotoxicity in children. (1989) (19)
Coming to terms: parents' response to a first cancer recurrence in their child. (1997) (19)
Pharmacokinetics of sustained serum methotrexate concentrations secondary to gastrointestinal obstruction. (1981) (18)
A pilot study of vincristine, ifosfamide, and doxorubicin in the treatment of pediatric non-rhabdomyosarcoma soft tissue sarcomas. (1998) (18)
Ifosfamide in pediatric malignant solid tumors (2004) (18)
Family history of cancer in children and young adults with colorectal cancer. (1999) (18)
Secondary non-Hodgkin's lymphoma after treatment for childhood cancer. (1991) (18)
Metastatic involvement of the heart in childhood rhabdomyosarcoma (1973) (18)
Refining therapeutic strategies for patients with resistant Wilm's tumor. (1994) (18)
Carboplatin (CBDCA), iproplatin (CHIP), and high dose cisplatin in hypertonic saline evaluated for tubular nephrotoxicity (2004) (18)
Clear cell sarcoma of soft tissues in children and young adults: the St. Jude Children's Research Hospital experience. (1999) (18)
Phase I trial of 9-aminocamptothecin in children with refractory solid tumors: a Pediatric Oncology Group study. (1998) (18)
Retroperitoneal rhabdomyosarcoma in children. Results of multimodality therapy (1980) (17)
Cisplatin disposition in children and adolescents with cancer (2004) (17)
Childhood rhabdomyosarcoma of the extremity: Results of combined modality therapy (1977) (17)
Multiple colorectal carcinomas, polyposis coli, and neurofibromatosis. (1988) (16)
Phase II study of 5‐fluorouracil/leucovorin for pediatric patients with malignant solid tumors (1994) (16)
Osteosarcoma During Pregnancy (1977) (16)
Response of pediatric malignant solid tumors following ifosfamide or ifosfamide/carboplatin/etoposide: a single hospital experience. (1996) (16)
Fatal congestive heart failure following mitoxantrone treatment in two children previously treated with doxorubicin and cisplatin. (1983) (16)
Current studies of ifosfamide for pediatric solid tumors and leukemia in the United States. (1992) (16)
Asynchronous bilateral retinoblastoma: the St. Jude Children's Research Hospital experience. (1995) (16)
Sarcomas (Other Than Ewing's) of flat bones in children and adolescents. A clinicopathologic study (1990) (16)
Transmedullary amputation and resection of metastases in combined therapy of osteosarcoma. (1977) (15)
Pancreatitis following cisplatin: a case report. (1985) (15)
Combination therapy including vincristine (NSC-67574) for malignant solid tumors in children. (1968) (15)
Phase I trial of mitoxantrone in children. (1985) (15)
Retinoblastoma metastatic to the ovary in a patient with Waardenburg syndrome. (2002) (15)
Asparaginase in combination chemotherapy for remission induction of childhood acute lymphocytic leukemia. (1973) (14)
Treatment of colorectal carcinoma in adolescents and young adults with surgery, 5-fluorouracil/leucovorin/interferon-alpha 2a and radiation therapy. (1999) (14)
A phase I study of ifosfamide with mesna given daily for 3 consecutive days to children with malignant solid tumors (1993) (14)
METASTATIC OSTEOSARCOMA TO THE LIVER AFTER TREATMENT FOR SYNOVIAL SARCOMA: A Case Report (2001) (13)
Treatment of childhood rhabdomyosarcoma at St. Jude Children's Research Hospital, 1962--78. (1981) (13)
Use of GM-CSF in children after high-dose chemotherapy. (1992) (13)
Osteosarcoma studies at St. Jude Children's Research Hospital from 1968 through 1990. (1993) (13)
PATTERNS OF ABDOMINAL RELAPSE AND ROLE OF SONOGRAPHY IN WILMS TUMOR (2002) (13)
Skeletal scintigraphy in patients with bilateral retinoblastoma (1990) (13)
Phase I Study of Flavone Acetic Acid (NSC 347512, LM975) in Patients with Pediatric Malignant Solid Tumors (1991) (13)
Multiple colorectal carcinomas, polyposis coli, and neurofibromatosis, followed by multiple glioblastoma multiforme. (1991) (12)
Phase I study of DMP 840 in pediatric patients with refractory solid tumors (2004) (12)
Use of chemotherapy for retinoblastoma (1998) (12)
Pharmacokinetic modeling of cisplatin disposition in children and adolescents with cancer (1982) (12)
Recombinant human TNF-alpha stimulates the secretion of granulocyte colony-stimulating factor in vivo. (1992) (12)
Evaluation of the child with a suspected malignant solid tumor. (1991) (12)
Safety, tolerability, antiemetic efficacy, and pharmacokinetics of oral dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapy. (1999) (12)
PHASE II EVALUATION OF CISPLATIN IN CHILDREN WITH NEUROBLASTOMA AND OTHER MALIGNANT SOLID TUMORS (1980) (12)
Osteosarcoma, fibrous dysplasia, and a chromosomal abnormality in a 3‐year‐old child (1980) (12)
Current progress in the treatment of the child with cancer. (1977) (12)
Extracortical bridging callus after limb salvage surgery about the knee. (1999) (12)
Sarcomas (other than Ewing's) of flat bones in children and adolescents. A clinicopathologic study. (1990) (11)
Outcome of treatment for pediatric sarcoma of the foot: a retrospective review over a 20-year period. (1997) (10)
Malignant melanoma in children: imaging spectrum (1996) (10)
Embryonal malignancies of unknown primary origin in children (1995) (10)
Complications of limb-sparing procedures using endoprosthetic replacements about the knee for pediatric skeletal sarcomas (2001) (10)
Secondary acute lymphoblastic leukemia in childhood. (1992) (9)
Effectiveness of paclitaxel in treating papillary serous carcinoma of the peritoneum in an adolescent. (1995) (9)
Normal computed tomograms of the brain in osteosarcoma patients treated with high‐dose methotrexate (1981) (9)
Epidemic Colon Cancer in Children and Adolescents (1982) (9)
Parotid carcinomas following the treatment of childhood acute lymphoblastic leukemia. (1995) (9)
Post‐irradiation malignant mesothelioma (1997) (8)
Malignant melanocytic lesions of unknown primary site in children and adolescents. (1995) (8)
Clinical Pharmacology of Bleomycin and Cisplatin (1982) (8)
Response of orbital and central nervous system metastases of retinoblastoma following treatment with cyclophosphamide/doxorubicin. (1987) (8)
Clinical studies of ifosfamide/mesna at St Jude Children's Research Hospital, 1983-1988. (1989) (8)
Coordinated treatment of childhood rhabdomyosarcoma. (1975) (7)
Comparison of Cytokines in Children with Recurrent Solid Tumors Treated with Intensive Chemotherapy (1998) (7)
Local-regional non-rhabdomyosarcomatous soft tissue sarcomas of the head and neck. (1990) (6)
Five-year survival after disseminated paratesticular rhabdomyosarcoma. (1977) (6)
Novantrone for childhood malignant solid tumors (2004) (6)
Phase I trial of subcutaneous interleukin‐1α in children with malignant solid tumors (1997) (6)
Bleomycin in xeroderma pigmentosum (1973) (6)
Phase I study of neocarzinostatin in children with cancer. (1978) (6)
Ifosfamide with mesna uroprotection and etoposide in recurrent, refractory acute leukemia in childhood: A pediatric oncology group study (1993) (6)
Topical topic. Use of chemotherapy for retinoblastoma. (1998) (6)
New drug development for pediatric oncology (2004) (5)
Phase I trial of subcutaneous interleukin-1 alpha in children with malignant solid tumors. (1997) (5)
Phase I trial of continuous infusion carboplatin and etoposide in children with refractory acute leukemia: a Pediatric Oncology Group study. (1994) (5)
Saturable elimination and saturable protein binding account for flavone acetic acid pharmacokinetics (1993) (5)
Mesna-Induced Urticaria (1988) (5)
Interpatient variability in oral (PO) absorption of topotecan (TPT) in children with relapsed solid tumors (1996) (5)
Chemotherapy of Osteosarcoma — An Overview (1980) (5)
Use of investigational drugs as initial therapy for childhood solid tumors. (1989) (5)
Imaging features of ovarian metastases from colonic adenocarcinoma in adolescents (2005) (5)
Local control in childhood rhabdomyosarcoma: analysis of radiation therapy parameters (1986) (4)
Ifosfamide/mesna and hematuria. (1987) (4)
Phase I clinical and pharmacokinetic study of bisantrene in refractory pediatric solid tumors (2004) (4)
Evaluation of a chemotherapeutic regimen for primary liver cancer in children. (1978) (4)
Chest radiographic features of thoracic metastatic disease in adolescents with colon cancer (2005) (4)
Clinical effects and pharmacokinetics of the fusion protein PIXY321 in children receiving myelosuppressive chemotherapy (1997) (4)
Evaluation of CHIP (iproplatin) in recurrent pediatric malignant solid tumors (1992) (4)
Ongoing clinical studies of ifosfamide for pediatric cancer in the United States. (1996) (4)
Outcome for patients with constitutional 13q chromosomal abnormalities and retinoblastoma. (1994) (4)
Comparison of crystalline and amorphous asparaginase in treatment of acute leukemia in children (1972) (4)
Soft tissue sarcomas in children. (1997) (3)
Influence of different treatment modalities on the curability of childhood rhabdomyosarcoma of the head or neck (1984) (3)
Multifocal osteosarcoma following retinoblastoma. (1999) (3)
A phase I study of sulofenur in refractory pediatric malignant solid tumors (2007) (3)
Treatment of osteosarcoma 1972-1997: an American perspective. (1998) (3)
Phase I trial of N-methylformamide in pediatric patients with refractory leukemias. (1987) (2)
Successful treatment of metastatic choriocarcinoma after DMP 840. (1995) (2)
11. Soft tissue sarcomas in children (1997) (2)
Letter: Hyperpigmentation of nails from doxorubicin. (1974) (2)
Factors Leading to Delay in the Diagnosis and Affecting Survival of Children With Head and Neck Rhabdomyosarcoma (1978) (2)
Risk of Delayed Second Primary Neoplasms After Treatment of Malignant Lymphoma (1993) (2)
Serum levels of methotrexate by the ligand binding assay after “HIGH‐DOSE” therapy for osteosarcoma (1979) (2)
Treatment outcome and dose-response relation” ship in infants younger than 1 year treated for retinoblastoma with primary irradiation (1996) (2)
SUCCESSFUL CHEMOPROPHYLAXIS FOR Pneumocystis carinii PNEUMONITIS (PCP) (1977) (2)
Coming to terms: Parental response to their child's first cancer recurrence☆ (1995) (1)
Radiographic findings in 13q-syndrome (2005) (1)
Acetylenic carbamate in childhood cancer (1971) (1)
"Multifocal synchronous osteosarcoma: the Scottish Bone Tumour Registry experience" by Jones et al., 1993. (1994) (1)
Cisplatin and doxorubicin for locally recurrent and metastatic childhood rhabdomyosarcoma. (1984) (1)
Childhood solid tumors. (1992) (1)
Case 50-1980: mixed malignant germ-cell tumor. (1981) (1)
Treatment of pseudomonas infections in leukemic children with carbenicillin and colistin. (1971) (1)
Phase I study of iproplatin in pediatric patients: a Pediatric Oncology Group Study. (1987) (1)
#552 Pharmacokinetically-dosed topotecan (TPT) 5 days/week for 2 consecutive weeks and weekly vincristine (Vcr) given to children with relapsed solid tumors (1999) (1)
Selected applications of methotrexate alone and in combination in osteosarcoma. (1981) (0)
Phase I study of 4′-deoxydoxorubicin (esorubicin) in children with malignant solid tumors (1989) (0)
Mesna Excretion and Ifosfamide Nephrotoxicity in Children1 (2006) (0)
Melanoma in children. (1995) (0)
82. Carbenicillin and Sodium Colistimethate Treatment of Pseudomonas Infections in Leukemic Children (1969) (0)
Survival of children with treated with combination neuroblastoma chemotherapy (1968) (0)
NORMAL COMPUTED TOMOGRAMS OF THE BRAIN IN OSTEOSARCOMA PATIENTS TREATED WITH HIGHDOSE METHOTREXATE (1981) (0)
Total ifosfamide excretion in the urine of pediatric patients and enantiomeric composition (1991) (0)
Neonatal cancer. (1992) (0)
Results of radiation therapy for retinoblastoma in children less than one year old (1989) (0)
Phase I S tudy o f C ombination T opotecan a nd C arboplatin in P ediatric S olid T umors (2002) (0)
Stress, Cancer, Death—A Pediatric Perspective (1986) (0)
Care of retinoblastoma patients and their families. (1982) (0)
Pediatric malignant solid tumors. (1993) (0)
Current and Future Management of Osteosarcoma (1980) (0)
Current and Future Management of Soft Tissue Sarcomas (1980) (0)
Pediatric malignant solid tumors. (1991) (0)
Anterior Versus Posterior Tumors in Patients with Retinoblastoma Treated with Primary Systemic Chemotherapy (2003) (0)
14. Thiabendazole in Visceral Larva Migrans (1969) (0)
Treatment o f I ntraocular R etinoblastoma W ith V incristine and C arboplatin (2003) (0)
Phase I Clinical and Pharmacokinetic Study of 4'-(9-Acridinylamino)-methanesulfon-m-anisidide in Children with Cancer1 (2006) (0)
Soft tissue sarcomas of children. (1991) (0)
Treatment of Childhood Soft Tissue Sarcomas (1980) (0)
Radiotherapy for unresectable or marginally resectable osteosarcoma (1999) (0)
Successful treatment of intraocular retinoblastoma with chemotherapy (2002) (0)
False-positive ketone tests: a bedside measure of urinary mesna (2004) (0)
Chemotherapy of metastatic retinoblastoma. (1962) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Charles B. Pratt?

Charles B. Pratt is affiliated with the following schools:

Charles B. Pratt's Academic­Influence.com Rankings

Why Is Charles B. Pratt Influential?

Charles B. Pratt's Published Works

Published Works

What Schools Are Affiliated With Charles B. Pratt?

Charles B. Pratt's AcademicInfluence.com Rankings